• Sensex82327.05-173.77(-0.21%)
  • Nifty25227.35-58(-0.22%)
  • USDINR88.69-0.1(-0.1%)
Online tarding Partner With Us
BSE Prices delayed by 5 minutes ! Prices as on   Oct 13, 2025   ABB India 5149.15 [ -0.70% ]ACC 1869.25 [ -0.82% ]Ambuja Cements 566.65 [ -0.40% ]Asian Paints Ltd. 2345.25 [ 0.21% ]Axis Bank Ltd. 1189.45 [ 0.79% ]Bajaj Auto 9071.25 [ 1.39% ]Bank of Baroda 268.15 [ 0.47% ]Bharti Airtel 1955.05 [ 0.80% ]Bharat Heavy Ele 234.65 [ -2.07% ]Bharat Petroleum 337.95 [ -0.22% ]Britannia Ind. 5868.45 [ -0.04% ]Cipla 1563.9 [ 0.15% ]Coal India 381.65 [ -0.68% ]Colgate Palm. 2220.55 [ -0.35% ]Dabur India 488 [ -0.34% ]DLF Ltd. 741.7 [ 0.18% ]Dr. Reddy's Labs 1261.95 [ -0.23% ]GAIL (India) 180.3 [ 0.70% ]Grasim Inds. 2795.35 [ -0.63% ]HCL Technologies 1494.7 [ 0.00% ]HDFC Bank 977.95 [ -0.30% ]Hero MotoCorp 5559.15 [ 1.08% ]Hindustan Unilever L 2492.25 [ -1.46% ]Hindalco Indus. 770 [ -0.49% ]ICICI Bank 1379.05 [ -0.12% ]Indian Hotels Co 727.05 [ -1.12% ]IndusInd Bank 759.55 [ -0.52% ]Infosys L 1493 [ -1.40% ]ITC Ltd. 399.1 [ -0.92% ]Jindal Steel 1008.6 [ -0.64% ]Kotak Mahindra Bank 2152.1 [ 0.12% ]L&T 3770.35 [ -0.34% ]Lupin Ltd. 1970.3 [ 0.54% ]Mahi. & Mahi 3459.25 [ 0.14% ]Maruti Suzuki India 16315.4 [ 0.24% ]MTNL 42.46 [ -1.09% ]Nestle India 1188.2 [ -0.96% ]NIIT Ltd. 105.55 [ -1.08% ]NMDC Ltd. 77.17 [ 0.05% ]NTPC 341.65 [ 0.63% ]ONGC 244 [ -0.91% ]Punj. NationlBak 116.95 [ -0.30% ]Power Grid Corpo 286.4 [ -0.95% ]Reliance Inds. 1375.1 [ -0.50% ]SBI 883 [ 0.26% ]Vedanta 479.45 [ -0.55% ]Shipping Corpn. 230.1 [ 3.56% ]Sun Pharma. 1668.5 [ -0.14% ]Tata Chemicals 910.5 [ 0.83% ]Tata Consumer Produc 1116.85 [ -0.82% ]Tata Motors 660.9 [ -2.67% ]Tata Steel 172.95 [ -0.49% ]Tata Power Co. 391.15 [ 0.28% ]Tata Consultancy 3007.15 [ -0.70% ]Tech Mahindra 1450.9 [ -0.44% ]UltraTech Cement 12171.4 [ -0.84% ]United Spirits 1315.8 [ -1.65% ]Wipro 245.05 [ -1.43% ]Zee Entertainment En 110.4 [ -0.90% ]
BSE

MARKETS

News Details

( As on 13/10/2025 17:09)

Lupin to Present Phase 1 Data on LNP3693 at ESMO Congress 2025

Lupin Limited will present findings from its Phase 1a clinical trial of LNP3693, a STING agonist, at the ESMO Congress 2025 in Berlin, Germany, scheduled from October 17–21, 2025. The presentation, titled “A Phase 1 Dose Escalation Study of LNP3693 (STING Agonist) in Patients with Advanced or Metastatic Solid Tumors & Lymphoma”, will be featured in the Investigational Immunotherapy session (Presentation Number 1553P) on October 19, 2025, from 09:00 to 17:00 CEST.

The data will offer insights into the safety, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity of LNP3693 in patients with solid tumors. LNP3693 is an investigational parenteral STING agonist under development by Lupin.

Commenting on the milestone, Vinita Gupta, CEO of Lupin, said,

“Following our successful presentation of LNP7457, a PRMT5 inhibitor, at ASCO in June 2025, it is a privilege to showcase the Phase 1 findings of LNP3693 at ESMO. This underscores the expertise of our team in oncology drug discovery, research, and clinical development in India.”

The complete presentation will be addressed during the official session, and all abstracts accepted at ESMO Congress 2025 will be published online on October 13, 2025, in the ESMO Abstract Book, a supplement to the journal Annals of Oncology.